
Cystic Fibrosis - Related Diabetes
Author(s) -
Marcin Makuch
Publication year - 2021
Publication title -
journal of education, health and sport
Language(s) - English
Resource type - Journals
ISSN - 2391-8306
DOI - 10.12775/jehs.2021.11.06.005
Subject(s) - cystic fibrosis related diabetes , cystic fibrosis , cystic fibrosis transmembrane conductance regulator , medicine , diabetes mellitus , pharmacotherapy , pathophysiology , disease , impaired glucose tolerance , gastroenterology , endocrinology , insulin resistance
Cystic fibrosis (CF) is life-shortening autosomal recessive disease, caused by mutations in the cystic fibrosis transmembrane conductance regulator protein. The most common of CF complications is cystic fibrosis-related diabetes (CFRD). The pathophysiology of CFRD is complex. The best test for screening and diagnosis of CFRD is the oral glucose tolerance test (OGTT). Insulin therapy is a treatment of choice in CFDR pharmacotherapy. An inseparable element of CFRD therapy is also physical activity and diet.